Chemotherapy-induced toxicities, such as neuropathy, are accepted consequences of some
effective therapies. However, neuropathy is also a primary dose-limiting complication of …

Introduction Chemotherapy‐induced neuropathies are one of the most common side effects
of cancer treatment, surpassing bone marrow suppression and kidney dysfunction …

The number of available therapies for hematologic malignancies continues to grow at a
rapid pace. Unfortunately, many of these treatments carry both central and peripheral …

Neurotoxicity is one of the risks and tolls taken in cancer therapy. Chemotherapy-induced
neurotoxicity is among the most frequent expected neurologic complications associated with …

Pre‐existing neuropathy, a not uncommon feature in oncologic patients, is a potential but
non‐confirmed risk factor to develop early or severe chemotherapy‐induced neuropathy …

Patients with cancer are living longer because of earlier diagnoses and remarkable
improvements in treatments. Unfortunately, both traditional chemotherapies and newer …

Abstract Purpose of Review The purpose of this study was to briefly discuss chemotherapy-
induced peripheral neuropathy (CIPN) and detail the most important and most recent …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and serious clinical
problem that affects many patients receiving cancer treatment. 1–4 This iatrogenic condition …

As the outcomes for many cancers have improved, treatment-related toxicities and their
impact on quality of life have become a more important part of oncologic care. Numerous …

Patients with cancer are living longer due to earlier diagnoses and steady improvement in
treatments. Unfortunately, neurologic complications from chemotherapy remain a significant …